Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nextleaf Solutions Ltd C.OILS

Alternate Symbol(s):  OILFF

Nextleaf is a federally regulated manufacturer and distributor of cannabis vapes and oils under its prohibition-era brand, Glacial Gold. The Company’s multi-patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. Nextleaf is a low-cost producer of cannabis oils, and supplies THC and CBD ingredients to partners across Canada. Nextleaf has been issued 19 U.S. patents and over 100 patents globally, on cannabinoid processing.


CSE:OILS - Post by User

Bullboard Posts
Comment by LastoftheFrankson Oct 06, 2020 12:55pm
93 Views
Post# 31673909

RE:RE:Extractors Still Needed based on Artificial Cannabinoids????

RE:RE:Extractors Still Needed based on Artificial Cannabinoids????

This is Biosynthesis. I literally just mentioned this in a previous longer post. They're primarily focused on medical, are years away and significant investment from being commercially viable.

If you read the release, their focus is on a multitude of other cannabinoids, as nobody holds the patents to CBD/THC. The 11% growth on CBG is 11% up on an already tiny number. These releases are mostly speculative, which is why they contain language like this:

It’s not only cheaper to engineer cannabinoids than to extract them from plants; synthesis has other advantages, companies say. Those include a purer, pharmaceutical grade product and none of the legal headaches that come with parts of the industry that touch cannabis plants.

Right now, making CBD means you’re in the farming business. By the time you harvest and extract and factor in the purification, it’s expensive,” said Dennis O’Neill, Biomedican’s chief investment officer. “And you can’t even produce the exact same product every time.”

If you're in the CBD space, your competition is the hemp industry, not cannabis. This is also a critique of vertically integrated companies. The industry has very much changed, Nextleaf produces both CBD and THC from either cannabis or hemp without growing anything. Purification tech has also since achieved final product stability/replication.

I agree with RM90090, synthetic cannabinoids will be PR spun into the "processed sugar" of cannabinoids, or disregarded entirely by people who only passingly pay attention to THC/CBD industry.

"Beyond meat" is an interesting comparison since the overwhelming majority of my vegetarian/vegan friends wont touch the stuff. It's synthetic processed food and its wildly unhealthy for you. Stigma could be a legitimate issue for them. 

 

Bullboard Posts